Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals


The cancer center will now bar top officials from sitting on outside boards of for-profit companies, and is conducting a wide-scale review of other policies. (Ny Times Science) More More

Similar stories

Recon: FDA Staff Unfazed by CV Signal in Amgen's Osteoporosis Trials; China Opens Probe Into Expired Polio Vaccines - Regulatory Focus

Recon: FDA Staff Unfazed by CV Signal in Amgen's Osteoporosis Trials; China Opens Probe Into Expired Polio Vaccines  Regulatory Focus

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. AstraZeneca Departures Continue as Medical Chief ...

Posted on 14 January 2019 | 3:00 am | Google News

Lab Strips DNA Scientist Watson Of His Last Remaining Honorary Positions Following Controversy Over Remarks On Race - Kaiser Health News

Lab Strips DNA Scientist Watson Of His Last Remaining Honorary Positions Following Controversy Over Remarks On Race  Kaiser Health News

Cold Spring Harbor Laboratory said it “unequivocally rejects the unsubstantiated and reckless personal opinions Dr. James D. Watson expressed on the subject ...

Posted on 14 January 2019 | 3:00 am | Google News

First Edition: January 14, 2019 - Kaiser Health News

First Edition: January 14, 2019  Kaiser Health News

Today's early morning highlights from the major news organizations.

Posted on 14 January 2019 | 3:00 am | Google News

Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals - The New York Times

Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals  The New York Times

The cancer center will now bar top officials from sitting on outside boards of for-profit companies, and is conducting a wide-scale review of other policies.

Posted on 11 January 2019 | 3:00 am | Google News

Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks - The New York Times

Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks  The New York Times

AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research unit.

Posted on 7 January 2019 | 3:00 am | Google News

Memorial Sloan Kettering’s Season of Turmoil - The New York Times

Memorial Sloan Kettering’s Season of Turmoil  The New York Times

One of the nation's top cancer hospitals has grappled with how to bring breakthrough treatments to market while remaining true to its mission.

Posted on 31 December 2018 | 3:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info